Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2022-11-18 00:00:00 ET · period of report 2022-11-16 · accession 0001689375-22-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-18 | 2022-11-16 | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $2.10 | +200 | 16.7K | +1% | +$420 |
| D | 2022-11-18 | 2022-11-16 | TRDA | WENTWORTH KORY JAMES | CFO | S - Sale+OE | $18.10 | -200 | 16.5K | -1% | -$3,620 |
| D | 2022-11-18 | 2022-11-16 | TRDA | WENTWORTH KORY JAMES | CFO | M - OptEx | $0.00 | -200 | 108.6K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-16 | M | A | 200 | $2.10 | 16,709 | D | — | — | (F2) The Form 4 filed by the reporting person on August 18, 2022 inadvertently understated the number of common shares owned following the transactions reported therein by 20 shares, an error that was carried forward onto the reporting person's subsequent Form 4 filings. Immediately prior to the transactions reported herein, the correct number of shares of common stock owned by the reporting person was 16,509 shares. |
| 2 | Common | Common Stock | 2022-11-16 | S | D | 200 | $18.10 | 16,509 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-11-16 | M | D | 200 | $0.00 | 108,607 | D | $2.10 · — to 2030-11-10 | 200 Common Stock | (F3) 25% of the shares subject to this option shall vest and become exercisable on November 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter. |